comparemela.com
Home
Live Updates
Intensity Therapeutics Presents Positive INT230-6 Data in Patients with Refractory Soft Tissue Sarcoma at the Connective Tissue Oncology Society Annual Meeting 2023 : comparemela.com
Intensity Therapeutics Presents Positive INT230-6 Data in Patients with Refractory Soft Tissue Sarcoma at the Connective Tissue Oncology Society Annual Meeting 2023
/PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS), a clinical-stage biotechnology company focused on the discovery and development of proprietary,...
Related Keywords
Ireland ,
Ottawa ,
Ontario ,
Canada ,
United States ,
Dublin ,
Westport ,
Mayo ,
David Rosen ,
Jonathan Nugent ,
Bristol Myers Squibb ,
Merck Sharpe Dohme ,
Christianf Meyer ,
Lewish Bender ,
Christian Frederick Meyer ,
Connective Tissue Oncology Society ,
Development Agreement ,
Johns Hopkins Sydney Kimmel Cancer Center ,
Company On Twitter Intensityinc ,
Ontario Institute Of Cancer Research ,
National Cancer Institute ,
Intensity Therapeutics Inc ,
Nasdaq ,
Ottawa Hospital Research Institute ,
Vaccine Branch ,
Intensity Therapeutics ,
Johns Hopkins Sydney Kimmel Cancer ,
Frederick Meyer ,
Assistant Professor ,
Sidney Kimmel Cancer Center ,
Johns Hopkins ,
Chief Executive Officer ,
Control Rate ,
Merck Sharpe ,
Ontario Institute ,
Cancer Research ,
Cooperative Research ,
Relations Contact ,
Health Care Amp Hospitals ,
Medical Pharmaceuticals ,
Pharmaceuticals ,
Biotechnology ,
Clinical Trials Amp Medical Discoveries ,
Surveys ,
Olls And Research ,
comparemela.com © 2020. All Rights Reserved.